InvestorsHub Logo

TheHound

12/16/14 12:13 AM

#3142 RE: nsomniyak #3141

No news is good news in regards to safety IMO.

NVIV is presenting at Biotech Showcase in January.

Mark Perrin, InVivo's CEO, said: "This (trial) is a major milestone not only for the company, but also for the field of traumatic SCI. InVivo is striving to provide benefit to the SCI patient population with such a huge unmet medical need, and this clinical trial is the first step. We look forward to communicating our progress and moving forward. InVivo will be making announcements after each site has joined the study, after each subject is enrolled, and once enrollment is re-opened for subsequent patients. We consider patient privacy of the utmost importance and will thus communicate any interim information according to industry standards. With the exception of dramatically positive or negative results, we will look to communicate progress at appropriate medical or scientific forums."

hogfan2

12/16/14 1:50 AM

#3143 RE: nsomniyak #3141

I'm expecting news in mid january and you should as well...that is when the next pt can be enrolled...3 months after the first pt...after 2nd has been in 3 months then its open enrollment on the remaining 3 pts...

yes i expect an update and you do too...hog

mikeysox21

12/16/14 3:08 AM

#3144 RE: nsomniyak #3141

First off pal, it was a simple observation. Don't start coming to this board trying to act all tough. No one hear said anything about them owing anything to the shareholders. If you read any previous posts from you would understand that everyone here is hoping for nothing but the best for Jordan and every other person associated with the trial. You need to take that crap someplace else.